In situ forming hydrogel and method using same

US10780145B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10780145-B2
Application numberUS-201715840621-A
CountryUS
Kind codeB2
Filing dateDec 13, 2017
Priority dateOct 12, 2011
Publication dateSep 22, 2020
Grant dateSep 22, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A hydrogel (I), comprising a polymer backbone wherein an aqueous solution of the hydrogel comprises a first lower critical solution temperature, and wherein the hydrogel is configured to be converted in vivo into a modified hydrogel, and wherein an aqueous solution of the modified hydrogel comprises a second lower critical solution temperature, and wherein the second lower critical solution temperature is greater than the first lower critical solution temperature.

First claim

Opening claim text (preview).

We claim: 1. A polymer for preparing a hydrogel, wherein the polymer is poly(NIPAAm-co-DBLA-co-JAAm) having a structure of: wherein: R1 and R2 are independently selected from the group consisting of H, alkyl, phenyl, benzyl, 2-cyanoprop-2-yl, 4-cyanopentanoic acid-4-ylethyl-2-propionate, sulfate, 2-[2-methoxypropan-2-yl)oxy]propan-2-yl, and 4-cyano-4-(ethylsulfanylthiocarbonyl)sulfanylpentanoic acid; a is about 10 to about 1,000, b is about 1 to about 250, and c is about 1 to about 500, and units of a, units of b, and units of c are arranged randomly and/or in blocks; a ratio of r:p is 19:3; and r is about 5 to about 2,500 and p is about 1 to about 1,000, and units of r and units of p are arranged randomly. 2. The polymer of claim 1 , wherein the units of r and the units of p are a random copolymer with a weight of about 1,000 Da. 3. The polymer of claim 1 , comprising the DBLA at about 4.7 mol % and JAAm at about 2.9 mol %. 4. The polymer of claim 1 , the polymer having a number average molecular weight Mn of about 13,100 g/mol. 5. The polymer of claim 1 , the polymer having a weight average molecular weight Mw of about 28,200 g/mol. 6. A hydrogel comprising: the polymer of claim 1 ; and water. 7. The hydrogel of claim 6 , wherein the units of r and the units of p are a random copolymer with a weight of 1,000 Da. 8. The hydrogel of claim 6 , comprising the DBLA at about 4.7 mol % and JAAm at about 2.9 mol %. 9. The hydrogel of claim 6 , the polymer having a number average molecular weight Mn of about 13,100 g/mol. 10. The hydrogel of claim 6 , the polymer having a weight average molecular weight Mw of about 28,200 g/mol.

Assignees

Inventors

Classifications

  • A61K9/06Primary

    Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)} · CPC title

  • Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone} · CPC title

  • Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title

  • Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title

  • A61K38/14Primary

    Peptides containing saccharide radicals; Derivatives thereof {, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10780145B2 cover?
A hydrogel (I), comprising a polymer backbone wherein an aqueous solution of the hydrogel comprises a first lower critical solution temperature, and wherein the hydrogel is configured to be converted in vivo into a modified hydrogel, and wherein an aqueous solution of the modified hydrogel comprises a second lower critical solution temperature, and wherein the second lower critical solution tem…
Who is the assignee on this patent?
Univ Arizona State, Banner Health, Arizona Board Of Regents A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizon
What technology area does this patent fall under?
Primary CPC classification A61K9/06. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).